Serum markers of bone and collagen turnover in patients with Cushing's syndrome and in subjects with adrenal incidentalomas

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 10, 1997, Pages 3303-3307

  Osella, G ^a,b   Terzolo, M ^a   Reimondo, G ^a   Piovesan, A ^a   Pia, A ^a   Termine, A ^a   Paccotti, P ^a   Angeli, A ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b SAN LUIGI GONZAGA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; GLUCOCORTICOID; OSTEOCALCIN;

ADRENAL CORTEX ADENOMA; ADULT; AGED; ARTICLE; BONE TURNOVER; CLINICAL ARTICLE; COLLAGEN METABOLISM; CONTROLLED STUDY; CUSHING SYNDROME; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TREATMENT INDICATION;

ADRENAL GLAND NEOPLASMS; ADULT; AGED; ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; BONE REMODELING; COLLAGEN; CUSHING SYNDROME; FEMALE; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; OSTEOCALCIN; PEPTIDE FRAGMENTS; PROCOLLAGEN; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0030882986     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.10.3303     Document Type: Article

References (35)

1. Kloos RT, Shapiro B, Gross MD. 1995 The adrenal incidentaloma. Curr Opin Endocrinol Diabetes. 2:222-230.
2. Osella G, Terzolo M, Borretta G, et al. 1994 Endocrine evaluation of incidentally discovered adrenal masses (incidentalomas). J Clin Endocrinol Metab. 79:1532-1539.
3. Beyer HS, Doe RP. 1986 Cortisol secretion by an incidentally discovered nonfunctional adrenal adenoma. J Clin Endocrinol Metab. 62:1317-1321.
4. Rosen HN, Swartz SL. 1992 Subtle glucocorticoid excess in patients with adrenal incidentaloma. Am J Med. 92:213-216.
5. Reincke M, Nieke J, Krestin GP, Saeger W, Allolio B, Winkelmann W. 1992 Preclinical Cushing's syndrome in adrenal "incidentalomas:" comparison with adrenal Cushing's syndrome. J Clin Endocrinol Metab. 75:826-832.
6. Bertagna C, Orth DN. 1981 Clinical and laboratory findings and results of therapy in 58 patients with adrenocortical tumours admitted to a single medical center (1951 to 1978). Am J Med. 71:855-875.
7. Charbonnel B, Chatal JF, Ozanne P. 1981 Does the corticoadrenal adenoma with "pre-Cushing's syndrome" exist?. J Nucl Med. 22:1059-1061.
8. Bogner U, Eggens U, Hensen J, Oelkers W. 1986 Incidentally discovered ACTH-dependent adrenal adenoma presenting as "pre-Cushing's svndrome." Acta Endocrinol (Copenh). 111:89-92.
9. Gross MD, Shapiro B. 1993 Clinical review 50: clinically silent adrenal masses. J Clin Endocrinol Metab. 77:885-888.
10. Delmas PD, Malaval L, Arlot ME, Meunier PJ. 1985 Serum bone gla protein compared to bone histomorphometry in endocrine disease. Bone 6339-341.
11. Epstein S. 1988 Serum and urinary markers of bone remodeling: assessment of bone turnover. Endocr Rev. 9:437-449.
12. Azria M. 1989 The value of biomarkers in detecting alterations in bone. Calcif Tissue Int. 45:7-11.
13. Garnero P, Delmas PD. 1993 Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease. J Clin Endocrinol Metab. 77:1046-1053.
14. Meikko J, Niemi S, Risteli L, Risteli J. 1990 Radioimmunassay of the carboxyterminal propeptide of human type I procollagen. Clin Chem. 36:1328-1332.
15. Risteli J, Elomaa I, Niemi S, Novamo A, Risteli L. 1993 Radioimmunoassay for the pyridinoline cross-linked carboxyterminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. Clin Chem. 39:635-640.
16. Prockop DJ, Kivirikko KI, Tuderman L, Gutzman LA. 1979 The biosynthesis of procollagen and its disorders. N Engl J Med. 301:13-23, 77-85.
17. Risteli J, Niemi S, Trivedi P, Mäentausta O, Mowat AT, Risteli L. 1988 Rapid equilibrium radioimmunoassay for the aminoterminal propeptide of human type III procollagen. Clin Chem. 34:715-718.
18. Dempster DW. 1989 Bone histomorphometry in glucococrticoid-induced osteoporosis. J Bone Miner Res. 4:137-141
19. Bressot C, Meunier PJ, Chapuy MC, Lejeune E, Edouard C, Darby AJ. 1979 Histomorphometric profile, pathophysiology and reversibility of corticosteroid-induced osteoporosis. Metab Bone Dis Rel Res. 1:303-311.
20. Prummel MF, Wiersinga WM, Lips P, Sanders GTB, Sauerwein HP. 1991 The course of biochemical parameters of bone turnover during treatment with corticosteroids. J Clin Endocrinol Metab. 72:382-386.
21. Sartorio A, Ambrosi B, Colombo P, Morabito F, Faglia G. 1988 Osteocalcin levels in Cushing's disease before and after treatment. Horm Metab Res. 20:70-77.
22. Ekenstam E, Stalenheim G, Hallgren R. 1988 The acute effect of high dose corticosteroid treatment on serum osteocalcin. Metabolism. 37:141-144.
23. Hahn TJ, Halstead LR, Baran DT. 1981 Effects of short term glucocorticoid administration on intestinal calcium adsorption and circulating vitamin D metabolite concentrations in man. J Clin Endocrinol Metab. 52:111-115.
24. Suzuki Y, Ichikawa Y, Saito E, Homma M. 1983 Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy. Metabolism. 32:151-156.
25. Findling JW, Adams ND, Lemann J, Gray RW, Thomas CJ, Tyrrell JB. 1982 Vitamin D metabolites and parathyroid hormone in Cushing's syndrome: relationship to calcium and phosphorus homeostasis. J Clin Endocrinol Metab. 54:1039-1044.
26. Hermus AR, Smals AG, Swinkels LM, et al. 1995 Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome. J Clin Endocrinol Metab. 80:2859-2865.
27. Terzolo M, Osella G, Ali A, et al. 1996 Different patterns of steroid secretion in patients with adrenal incidentaloma. J Clin Endocrinol Metab. 81:740-744.
28. Kloos RT, Gross MD, Francis IR, Korobkin M, Shapiro B. 1995 Incidentally discovered adrenal masses. Endocr Rev. 16:460-484.
29. Reznek RH, Armstrong P. 1994 Imaging in endocrinology. The adrenal gland. Clin Endocrinol (Oxf). 40:561-576.
30. Piovesan A, Terzolo M, Reimondo G, et al. 1994 Biochemical markers of bone and collagen turnover in acromegaly and Cushing's syndrome. Horm Metab Res. 26:234-237.
31. Terzolo M, Piovesan A, Osella G, et al. 1993 Serum levels of bone Gla-protein (osteocalcin, BGP) and carboxyterminal propeptide of type I procollagen (PICP) in acromegaly: effects of long-term octreotide treatment. Calcif Tissue Int. 52:188-191.
32. Kleerekopper M, Schiebinger RJ. 1995 Skeletal recovery after treatment of Cushing's: still room for improvement (editorial). J Clin Endocrinol Metab. 80:2856-2858.
33. Lo Cascio V, Bonucci E, Ballanti P, et al. 1987 Glucocorticoid osteoporosis: a longitudinal study. In: Christiansen C, Johansen J, Riis B, eds. Osteoporosis 1987. Copenhagen: Osteo Press; 1044-1046.
34. Sambrook P, Birmingham J, Kempler S, et al. 1990 Corticosteroid effects on proximal femur bone loss. J Bone Miner Res. 5:1211-1216.
35. Ambrosi B, Peverelli S, Passini E, et al. 1995 Abnormalities of endocrine function in patients with clinically "silent" adrenal masses. Eur J Endocrinol. 132:422-428.